Abstract

e18541Background: Advances in precision medicine (PM) offer new promises for cancer care delivery. Genomic analysis provides guidance on selecting molecularly targeted therapies for favorable outco...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Communicating Value: Use of a Novel Framework in the Assessment of an Enhanced Recovery Initiative.
Casey J Allen ... Robert S Kaplan
ANNALS of SURGERY | VOL. 273
Casey J Allen, et. al.Casey J Allen ... Robert S Kaplan
16 Jun 2020
Integration of clinical pathway construction and hospital information system in intensive care unit is the core of digitalized hospital: experience of clinical pathway construction in Liuzhou Worker's Hospital from 2016 to 2018
... Song Mo
Chinese critical care medicine | VOL. 31
, et. al. ... Song Mo
01 Jan 2019
Analysis of Cesarean Section Clinical Pathway Compliance at a Private Hospital in Yogyakarta
Beta Haninditya ... Tri Murti Andayani
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) | VOL. 9
Beta Haninditya, et. al.Beta Haninditya ... Tri Murti Andayani
29 Mar 2019
Evaluación del impacto de una trayectoria clínica sobre el ictus isquémico
Margarita Esteve ... Joan Berenguer
Gaceta Sanitaria | VOL. 18
Margarita Esteve, et. al.Margarita Esteve ... Joan Berenguer
01 Jan 2004
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
Steven J Katz ... Allison W Kurian
Journal of Clinical Oncology | VOL. -
Steven J Katz, et. al.Steven J Katz ... Allison W Kurian
15 Jul 2024
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
Yoon-Koo Kang ... Sung Hoon Noh
Journal of Clinical Oncology | VOL. -
Yoon-Koo Kang, et. al.Yoon-Koo Kang ... Sung Hoon Noh
12 Jul 2024
Individualized Local Recurrence Estimates for Ductal Carcinoma In Situ.
Laura E G Warren ... Jennifer R Bellon
Journal of Clinical Oncology | VOL. -
Laura E G Warren, et. al.Laura E G Warren ... Jennifer R Bellon
11 Jul 2024
Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1-Mutated Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer?
Aoba Okeya ... Chikako Shimizu
Journal of Clinical Oncology | VOL. -
Aoba Okeya, et. al.Aoba Okeya ... Chikako Shimizu
11 Jul 2024
View more papers